Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Virtual Attendance is optimal for an audience who would like to have access to workshop content from anywhere, eliminate travel time and expenses, and who would like to have the flexibility to attend dynamic sessions/presentations at preferred times
A 2025 systematic review and meta-analysis of tirzepatide (Masson and colleagues, Reviews in Endocrine and Metabolic Disorders ) found that across seven randomized trials, tirzepatide reduced hsCRP by about 33% and IL-6 by about 18% compared to placebo and the effect held even at the lowest 5 mg dose
After a consultation with the dermatology experts at Skin Wellness, we can create a personalized treatment plan targeting your unique skin care needs and goals
The results showed that JMF4073 inhibits both TMPK and CMPK at a similar IC 50 , 0.17 M, whereas YMU1 is less potent to CMPK (Fig